Paper3854
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
Creese I and 2 others. Science, 1976. Cited by 1,843 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Papers, record 3854. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3854
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Butyrophenones | Major topic |
| Dopamine | Major topic |
| Receptors, Drug | Major topic |
| Schizophrenia | Major topic |
| Adenylyl Cyclases | |
| Animals | |
| Binding, Competitive | |
| Corpus Striatum | |
| Dopamine Antagonists | |
| Haloperidol | |
| Humans | |
| Olfactory Bulb | |
| Phenothiazines | |
| Structure-Activity Relationship |
Source PubMed
Cited by461
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,843 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,931,251 | Two Coordinates for Dopamine in the Basal Ganglia. | NeuroSci | 2026 | https://conductscience.org/library/papers/42931251 | PubMed |
| 42,927,497 | Volatilomics in psychiatric biomarker research: from odor signatures to multiomic integration. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/42927497 | PubMed |
| 42,803,324 | Lost in translation: why don't dopamine D2 antagonists cure addictions? | J Psychiatry Neurosci | 2026 | https://conductscience.org/library/papers/42803324 | PubMed |
| 42,446,851 | Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective. | Pharmaceut Med | 2026 | https://conductscience.org/library/papers/42446851 | PubMed |
| 42,016,325 | SARS-CoV-2 Spike Protein S1 Subunit Induces Neuroinflammation Via Microglial Kv1.3 Channel. | Biol Psychiatry Glob Open Sci | 2026 | https://conductscience.org/library/papers/42016325 | PubMed |
| 41,750,209 | Association Between Caffeine Levels and Symptom Profile in Schizophrenia: Results from a Cohort Study in Central Greece. | Brain Sci | 2026 | https://conductscience.org/library/papers/41750209 | PubMed |
| 41,664,080 | The gene expression landscape of disease genes. | Genome Biol | 2026 | https://conductscience.org/library/papers/41664080 | PubMed |
| 41,171,924 | Dorsomedial striatum monitors unreliability of current action policy and probes alternative one via the indirect pathway. | Sci Adv | 2025 | https://conductscience.org/library/papers/41171924 | PubMed |
| 41,132,847 | Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development. | Acta Pharm Sin B | 2025 | https://conductscience.org/library/papers/41132847 | PubMed |
| 41,102,143 | The neural basis for uncertainty processing in hierarchical decision making. | Nat Commun | 2025 | https://conductscience.org/library/papers/41102143 | PubMed |
| 41,052,274 | Antipsychotic drugs at 75: the past, present, and future of psychosis management. | Br Med Bull | 2025 | https://conductscience.org/library/papers/41052274 | PubMed |
| 41,031,373 | Toward biomimetic optogenetics: Drug-free activation of acute opiate reward. | iScience | 2025 | https://conductscience.org/library/papers/41031373 | PubMed |
| 40,983,366 | D1/D5 receptor activation promotes long-term potentiation and synaptic tagging/capture in hippocampal area CA2. | FEBS J | 2026 | https://conductscience.org/library/papers/40983366 | PubMed |
| 40,970,410 | HMG-CoA reductase inhibitors (statins) versus placebo for people with schizophrenia. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40970410 | PubMed |
| 40,806,385 | Serotonin Modulation of Dorsoventral Hippocampus in Physiology and Schizophrenia. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806385 | PubMed |
| 40,655,977 | Common changes in rat cortical gene expression after chronic treatment with chlorpromazine and haloperidol may be related to their antipsychotic efficacy. | Neurosci Appl | 2023 | https://conductscience.org/library/papers/40655977 | PubMed |
| 40,405,017 | An ace in the hole? Opportunities and limits of using mice to understand schizophrenia neurobiology. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/40405017 | PubMed |
| 40,340,862 | Chlorpromazine directly inhibits Kv1.3 channels by facilitating the inactivation of channels. | Mol Brain | 2025 | https://conductscience.org/library/papers/40340862 | PubMed |
| 40,269,187 | LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/40269187 | PubMed |
| 40,141,736 | Third-Generation Antipsychotics: The Quest for the Key to Neurotrophism. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40141736 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3854
GET https://conductscience.org/api/papers/v1/3854/cited_by?page=2